Home > Financial Ratios > AURO LABORATORIES

AURO LABORATORIES
Core EBITDA Growth

    Back to All Ratios
COMMUNITY POLL
for AURO LABORATORIES
Please provide your vote to see the results

AURO LABORATORIES Last 5 Year Core EBITDA Growth History

[Standalone]

Mar2024Mar2023Mar2022Mar2021Mar2020
   Core EBITDA Growth(%) 128.22-6.71-52.3565.67-8.91

What is the latest Core EBITDA Growth ratio of AURO LABORATORIES ?

The latest Core EBITDA Growth ratio of AURO LABORATORIES is 128.22 based on Mar2024 Standalone results.
Year Core EBITDA Growth
Mar2024128.22
Mar2023-6.71
Mar2022-52.35
Mar202165.67
Mar2020-8.91

How is Core EBITDA Growth of AURO LABORATORIES Trending?

Years Core EBITDA Growth % Change
Mar2024 128.22
Positive
Mar2023 -6.71
Negative
Mar2022 -52.35
Negative
Mar2021 65.67
Positive
Mar2020 -8.91 -

Other Financial Ratios of AURO LABORATORIES


Compare Core EBITDA Growth ratio of peers of AURO LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
AURO LABORATORIES ₹149.7 Cr 4% -7.6% 24.2% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹384,469.0 Cr 2.3% -0.4% -12.4% Stock Analytics
DIVIS LABORATORIES ₹160,672.0 Cr 0% 1.1% 10.7% Stock Analytics
CIPLA ₹125,034.0 Cr 2.1% 3.5% -4.4% Stock Analytics
TORRENT PHARMACEUTICALS ₹119,542.0 Cr -1.2% -1.7% 4.5% Stock Analytics
DR REDDYS LABORATORIES ₹108,571.0 Cr 5.3% 7.9% -2% Stock Analytics


AURO LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
AURO LABORATORIES

4%

-7.6%

24.2%

SENSEX

1.2%

1.9%

-0.2%


You may also like the below Video Courses